Publication

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

CertaraFebruary 23, 2024

Blog

What is kanban and how does it optimize early drug discovery projects?

Discover how Kanban optimizes early drug discovery projects. Visualize workflow, improve collaboration, and increase productivity…

CertaraSeptember 27, 2023

Publication

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…

CertaraJune 28, 2023

Conference

American College of Toxicology 2026 Annual Meeting

– – Booth

Kevin Snyder, PhDMay 24, 2023

Conference

ACoP 2026

CertaraMay 24, 2023

Publication

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Explore how tumor growth inhibition modeling can support go/no-go decisions in early Phase Ib/II oncology…

CertaraMarch 24, 2023

Conference

Asembia AXS26 Summit

–

CertaraFebruary 15, 2023

Conference

ISPOR International Annual Conference 2026

–

CertaraFebruary 15, 2023

Blog

Why you should select your drug formulation before starting clinical studies

Drug developers often rush through the discovery process to get into human testing. Most are…

CertaraOctober 28, 2022

Blog

5 steps to satisfy new EU-CTR requirements for plain language summaries of clinical study results

For the first time, the European Medicines Agency (EMA) has passed new regulations to help…

CertaraSeptember 27, 2022

Drug Development

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

What is kanban and how does it optimize early drug discovery projects?

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

American College of Toxicology 2026 Annual Meeting

ACoP 2026

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Asembia AXS26 Summit

ISPOR International Annual Conference 2026

Why you should select your drug formulation before starting clinical studies

5 steps to satisfy new EU-CTR requirements for plain language summaries of clinical study results

Newsletter sign up

Quick links

Solutions

Contact